comparemela.com

Page 17 - Duke Cancer Institute News Today : Breaking News, Live Updates & Top Stories | Vimarsana

RSNA 2023 Day One Highlights: Artificial Intelligence (AI), Radiomics, Regulatory Issues and Health Equity in Imaging

The first day of the 109th Scientific Sessions and Annual Meeting of the Radiological Society of North America, RSNA 2023, delivered an engaging and highly-anticipated range of education and scientific sessions, technical exhibit floor demonstrations and news developments. Highlights from day one are summarized in this snapshot summary of several key programs and professional insights.

Urban environments linked to higher breast cancer incidence

Researchers identify biomarkers for checkpoint inhibitor-induced hyperprogression of melanoma cells

Duke Cancer Institute researchers have identified potential biomarkers that predict the likelihood for checkpoint inhibitor drugs to backfire, driving hyper-progression of melanoma cells instead of unleashing the immune system to fight them.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.